US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare ...
The U.S. Food and Drug Administration (FDA) has approved Jascayd (nerandomilast) tablets to treat idiopathic pulmonary fibrosis (IPF), a rare ...
The FDA has granted approval to begin clinical trials of the AD-NP1 drug. It is a first-in-class drug for tissue ...
The FDA has introduced a pilot fast-track review programme aimed at accelerating reviews for generic medicines tested and manufactured within ...
Eli Lilly and Company has received U.S. Food and Drug Administration (FDA) approval for Inluriyo (imlunestrant, 200 mg tablets), an ...
The U.S. Food and Drug Administration (FDA) has started the process to approve leucovorin calcium tablets as a treatment for ...
The U.S. Food and Drug Administration has granted approval to Incyte’s eczema cream, Opzelura, for use in children aged 2 ...
Amneal Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company’s sodium ...
The U.S. Food and Drug Administration (FDA) announced that it will issue approximately 100 cease-and-desist enforcement notices alongside thousands of ...
The U.S. Food and Drug Administration has granted approval to Johnson & Johnson’s drug delivery system for a specific type ...
The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.